Literature DB >> 16699852

Acute necrotizing esophagitis: role of nonsteroidal anti-inflammatory drugs.

Hiroshi Yasuda1, Masaya Yamada, Yutaka Endo, Kazuaki Inoue, Makoto Yoshiba.   

Abstract

BACKGROUND: Acute necrotizing esophagitis (ANE) is a rarely described entity that is thought to be a cause of upper gastrointestinal (UGI) bleeding, The present study examined the incidence of ANE among patients with UGI bleeding, as well as the clinical features of ANE, and the coexisting illnesses and medication histories of ANE patients.
METHODS: A retrospective analysis of clinical and endoscopic findings and the clinical course in 16 patients with ANE was carried out over a 3-year period.
RESULTS: We observed 16 patients (6%) of ANE in 239 patients with UGI bleeding during the 3-year period. The average age of the patients was 62.5 years. The lesions predominantly affected the lower third of the esophagus, and hiatal hernia was the most common (63%) coexisting endoscopic finding. All patients had coexisting disease. Fifty percent of patients with ANE (eight patients) had taken nonsteroidal anti-inflammatory drugs (NSAIDs). ANE also occurred in four patients with diabetic ketoacidosis. Supportive therapy, including parenteral nutrition and administration of a proton pump inhibitor, was effective.
CONCLUSIONS: ANE is more common than has been previously reported, and it should be included in the differential diagnosis of UGI bleeding. ANE could be characterized as an "acute esophageal mucosal lesion," particularly in aged patients with hiatal hernia and among those who consume NSAIDs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699852     DOI: 10.1007/s00535-005-1741-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  17 in total

1.  Black esophagus associated with herpes esophagitis.

Authors:  P Cattan; E Cuillerier; C Cellier; F Carnot; B Landi; A Dusoleil; J P Barbier
Journal:  Gastrointest Endosc       Date:  1999-01       Impact factor: 9.427

2.  Effect of aspirin, alcohol, and pepsin on mucosal permeability of esophageal mucosa.

Authors:  S Safaie-Shirazi; W L Zike; M Brubacher; L DenBesten
Journal:  Surg Forum       Date:  1974

3.  Idiopathic acute esophageal necrosis: not necessarily a terminal event.

Authors:  M Moretó; E Ojembarrena; M Zaballa; J G Tánago; S Ibánez
Journal:  Endoscopy       Date:  1993-10       Impact factor: 10.093

4.  Risk factors for erosive reflux esophagitis: a case-control study.

Authors:  B Avidan; A Sonnenberg; T G Schnell; S J Sontag
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

Review 5.  NSAIDs and the oesophagus.

Authors:  J C Mason
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-04       Impact factor: 2.566

Review 6.  Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes.

Authors:  Dennis M Jensen
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

7.  Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs.

Authors:  H B El-Serag; A Sonnenberg
Journal:  Am J Gastroenterol       Date:  1997-01       Impact factor: 10.864

8.  Acute necrotizing esophagitis.

Authors:  S P Goldenberg; S L Wain; P Marignani
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

9.  Prostaglandins in the treatment of reflux oesophagitis: double-blind placebo controlled clinical trial.

Authors:  A D Purushotham; G R Gray; D T Hansell
Journal:  J R Coll Surg Edinb       Date:  1991-08

10.  Prevalence, etiology, and prognostic significance of upper gastrointestinal hemorrhage in diabetic ketoacidosis.

Authors:  D O Faigel; D C Metz
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

View more
  18 in total

1.  Black esophagus: an uncommon cause of upper gastrointestinal bleeding.

Authors:  Michalis Galanopoulos; Stylianos Anastasiadis; Emmanuel Archavlis; Gerassimos John Mantzaris
Journal:  Intern Emerg Med       Date:  2015-11-24       Impact factor: 3.397

2.  Advanced endoscopic imaging in black esophagus.

Authors:  Yuto Shimamura; Kenji Nakamura; Mai Ego; Fumio Omata
Journal:  Can J Gastroenterol Hepatol       Date:  2014-10

3.  "Black Esophagus" and Gastric Volvulus Following Slipped Laparoscopic Adjustable Gastric Band.

Authors:  Carolyn Moore; Leslie Ray Matthews; Omar Danner; Assad Taha; Aviva Bashan-Gilzenrat; Jonathan Nguyen; Ed Childs; Kahdi Udobi
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

4.  Black esophagus: new insights and multicenter international experience in 2014.

Authors:  Grigoriy E Gurvits; Karen Cherian; Mohamed Nafe Shami; Ravikiran Korabathina; Emad Mokhtar Abu El-Nader; Krishna Rayapudi; Frederick J Gandolfo; Mohammad Alshumrany; Hiren Patel; Deepshikha N Chowdhury; Aris Tsiakos
Journal:  Dig Dis Sci       Date:  2014-10-09       Impact factor: 3.199

Review 5.  Rare complications of pediatric diabetic ketoacidosis.

Authors:  Shara R Bialo; Sungeeta Agrawal; Charlotte M Boney; Jose Bernardo Quintos
Journal:  World J Diabetes       Date:  2015-02-15

Review 6.  Black esophagus: acute esophageal necrosis syndrome.

Authors:  Grigoriy E Gurvits
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

7.  Gurvits syndrome: a case of acute esophageal necrosis associated with diabetic ketoacidosis.

Authors:  Daisuke Kitawaki; Atsushi Nishida; Keitaro Sakai; Yuji Owaki; Kyohei Nishino; Yoshika Noda; Hirotsugu Imaeda
Journal:  BMC Gastroenterol       Date:  2022-06-02       Impact factor: 2.847

8.  Black oesophagus.

Authors:  Olga Pereira; João Figueira-Coelho; Bárbara Picado; José Neves Costa
Journal:  BMJ Case Rep       Date:  2013-01-29

9.  The dark side of the esophagus.

Authors:  Daniela Martins; Rita Marques; Pedro Costa; João Pinto de Sousa
Journal:  Autops Case Rep       Date:  2021-05-06

10.  Protective Effect of ECQ on Rat Reflux Esophagitis Model.

Authors:  Hyeon-Soon Jang; Jeong Hoon Han; Jun Yeong Jeong; Uy Dong Sohn
Journal:  Korean J Physiol Pharmacol       Date:  2012-12-10       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.